MAPT and Alzheimer disease: Instead, through multi-component and multi-pathway mechanisms, it directly or indirectly regulates core pathological markers of AD such as Aβ and tau while eliminating ROS and inhibiting apoptosis, thereby exerting neuroprotective effects.